ESSA Pharma SG&A Expense (Quarterly) Insights

ESSA Pharma Inc (EPIX)

6.97 +0.02 (+0.29%) USD | NASDAQ | May 03, 16:00

6.97 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	2.425M
September 30, 2023	2.085M
June 30, 2023	2.812M
March 31, 2023	3.885M
December 31, 2022	2.583M
September 30, 2022	2.767M
June 30, 2022	2.760M
March 31, 2022	3.722M
December 31, 2021	3.032M
September 30, 2021	2.914M
June 30, 2021	3.092M
March 31, 2021	4.588M
December 31, 2020	2.181M
September 30, 2020	2.173M
June 30, 2020	2.143M
March 31, 2020	4.836M
December 31, 2019	2.112M
September 30, 2019	1.246M
June 30, 2019	1.209M
March 31, 2019	1.758M
December 31, 2018	1.247M

Date	Value
September 30, 2018	1.207M
June 30, 2018	1.570M
March 31, 2018	2.170M
December 31, 2017	0.9484M
September 30, 2017	1.094M
June 30, 2017	1.291M
March 31, 2017	1.352M
December 31, 2016	1.358M
September 30, 2016	1.220M
June 30, 2016	1.289M
March 31, 2016	1.858M
December 31, 2015	1.210M
September 30, 2015	2.158M
June 30, 2015	1.057M
March 31, 2015	1.393M
December 31, 2014	0.6886M
September 30, 2014	0.6185M
June 30, 2014	0.3143M
March 31, 2014	0.1014M
December 31, 2013	0.1325M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.209M

Minimum

Jun 2019

4.836M

Maximum

Mar 2020

2.767M

Average

2.760M

Median

Jun 2022

SG&A Expense (Quarterly) Benchmarks